MML Investors Services LLC increased its position in Stryker Co. (NYSE:SYK) by 14.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 3,746 shares of the medical technology company’s stock after acquiring an additional 482 shares during the quarter. MML Investors Services LLC’s holdings in Stryker were worth $580,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Cornerstone Capital Management Holdings LLC. grew its holdings in shares of Stryker by 3.1% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 55,255 shares of the medical technology company’s stock worth $7,847,000 after acquiring an additional 1,683 shares during the period. Signature Estate & Investment Advisors LLC lifted its position in Stryker by 5.7% during the fourth quarter. Signature Estate & Investment Advisors LLC now owns 14,958 shares of the medical technology company’s stock valued at $2,316,000 after purchasing an additional 804 shares in the last quarter. Steward Partners Investment Advisory LLC purchased a new position in Stryker during the third quarter valued at $538,000. State of Alaska Department of Revenue lifted its position in Stryker by 216.4% during the fourth quarter. State of Alaska Department of Revenue now owns 48,095 shares of the medical technology company’s stock valued at $7,445,000 after purchasing an additional 32,892 shares in the last quarter. Finally, Nuance Investments LLC lifted its position in Stryker by 10.8% during the third quarter. Nuance Investments LLC now owns 24,624 shares of the medical technology company’s stock valued at $3,497,000 after purchasing an additional 2,406 shares in the last quarter. 75.71% of the stock is owned by institutional investors.
In other news, insider Lonny J. Carpenter sold 5,000 shares of Stryker stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $163.76, for a total value of $818,800.00. Following the sale, the insider now directly owns 94,253 shares of the company’s stock, valued at $15,434,871.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard E. Cox, Jr. sold 7,400 shares of Stryker stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $164.09, for a total value of $1,214,266.00. The disclosure for this sale can be found here. Insiders sold 43,611 shares of company stock worth $7,178,719 over the last 90 days. Company insiders own 7.40% of the company’s stock.
Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.95 by $0.01. Stryker had a return on equity of 24.56% and a net margin of 8.20%. The business had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.42 billion. During the same period in the previous year, the business earned $1.78 earnings per share. The business’s revenue was up 9.9% on a year-over-year basis. sell-side analysts predict that Stryker Co. will post 7.12 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be given a $0.47 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $1.88 annualized dividend and a dividend yield of 1.12%. Stryker’s payout ratio is 70.15%.
Several equities analysts recently weighed in on the company. Needham & Company LLC reiterated a “hold” rating on shares of Stryker in a research report on Wednesday, January 31st. Piper Jaffray Companies reiterated a “buy” rating and set a $170.00 target price on shares of Stryker in a research report on Wednesday, January 31st. Robert W. Baird upgraded Stryker from a “neutral” rating to an “outperform” rating in a research report on Friday, November 24th. Cantor Fitzgerald reiterated a “neutral” rating and set a $163.00 target price on shares of Stryker in a research report on Friday, January 5th. Finally, Guggenheim reiterated a “buy” rating on shares of Stryker in a research report on Wednesday, January 31st. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $164.76.
ILLEGAL ACTIVITY WARNING: “Stryker Co. (SYK) Shares Bought by MML Investors Services LLC” was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2018/03/17/stryker-co-syk-shares-bought-by-mml-investors-services-llc.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.